Adroit Biomed Limited, a active public limited company, was established on 10 December 2009 in Mumbai, Maharashtra, India. Engaging in personal care & skincare products within the trade sector, it holds CIN: U22100MH2009PLC197761. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 Cr and a paid-up capital of ₹4.40 M.
Formerly known as Adroit Biomed Private Limited, Adroit Digital Ideas Private Limited. It upholds a compliant status. Employing 135 professional, Its leadership includes Aniruddha Singh (Additional Director), Vikas Gupta (Additional Director), Nitin Agrawal (Additional Director). Past directors included Sameer Ashok Paigankar, Dilip Pawar, Ajit Shriniwas Marathe. It holds ₹5.00 Cr open charges and ₹2.75 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit No F-115, 1St Floor, Kanakia Zillion, Bkc Annexure, Lbs/Cst Road, Kurla (West), ,, Mumbai, Maharashtra, 400070.
U22100MH2009PLC197761
197761
10 December 2009
₹2.50 Cr
₹4.40 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Adroit Biomed Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aniruddha Singh | Additional Director | 26 May 2025 | Current |
| Vikas Gupta | Additional Director | 17 Apr 2025 | Current |
| Nitin Agrawal | Additional Director | 26 May 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Director | 12 Nov 2016 | Past |
| Pramod Abcsdd | Director | 17 Apr 2025 | Past |
| Pramod Abcsdd | Director | 17 Apr 2025 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Director | 04 Dec 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Adroit Biomed Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.86% increase. The company also saw a slight decrease in profitability, with a 6.19% decrease in profit. The company's net worth Soared by an impressive increase of 29.56%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Adroit Biomed had a promoter holding of 81.82% and a public holding of 18.17%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹50,000,000.00
₹27,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Oct 2023 | Others | ₹5.00 Cr | Open |
| 21 Apr 2013 | Others | ₹2.75 Cr | Satisfied |
Explore comprehensive loan charge details -
Adroit Biomed has a workforce of 135 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Adroit Biomed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adroit Biomed's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others of Rs. 5.00 Cr registered on 11 Oct 2023 with Charge ID 100838248 was modified on 19 Sep 2025. was completed.
Progress on Aniruddha Singh was appointed as a Additional Director was appointed as a Additional Director on 26 May 2025 & has been associated with this company since 6 months 29 days . was documented.
Progress on Nitin Agrawal was appointed as a Additional Director was appointed as a Additional Director on 26 May 2025 & has been associated with this company since 6 months 29 days . was documented.
Progress on Vikas Gupta was appointed as a Additional Director was appointed as a Additional Director on 17 Apr 2025 & has been associated with this company since 8 months 6 days . was documented.
Adroit Biomed Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Adroit Biomed Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The CIN of Adroit Biomed Limited is U22100MH2009PLC197761.
Adroit Biomed Limited is headquartered at Unit No F-115, 1St Floor, Kanakia Zillion, Bkc Annexure, Lbs/Cst Road, Kurla (West), ,, Mumbai, Maharashtra, 400070.
Adroit Biomed Limited was incorporated on 10 December 2009.
The current directors of Adroit Biomed Limited are
The primary industry of Adroit Biomed Limited is Trade.
Adroit Biomed Limited is unlisted.
The authorized capital of Adroit Biomed Limited is ₹2.50 Cr, and the paid-up capital is ₹4.40 M.
The compliance status of Adroit Biomed Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX